Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Multicentre Prospective Cohort Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
A multicenter prospective cohort study in India evaluating the gastric precancerous epithelial pathway using high-definition endoscopy and h…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer [NA]
This clinical trial update describes a fluorescence-guided sentinel lymph node navigation strategy using laparoscopic-endoscopic cooperation…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial [Phase 2]
A Phase 2 randomized controlled trial compares VRT106-based pressurized intraperitoneal aerosol chemotherapy with standard PIPAC in advanced…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma [Phase 2]
This Clinical Trials update notes a Phase II neoadjuvant trial combining thymosin alpha-1, a PD-1 inhibitor, and chemoradiotherapy for stage…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) [Phase 2]
AstraZeneca's Dato-DXd is being studied as a single agent and in combination with other anti-cancer drugs in an ongoing Phase 2 trial for ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: IBI343 in Combination Therapy for Advanced Malignant Solid Tumors [Phase 2]
This is a Phase 2 clinical trial update for IBI343 in combination therapy targeting CLDN18.2-positive advanced solid tumors, including gastr…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports on a Phase 1 trial testing the combination of sonidegib and pembrolizumab in patients with various advanced solid tumors…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification [Phase 1]
BeiGene is conducting a first-in-human Phase 1 study of BGB-53038, a pan-KRAS inhibitor, as a monotherapy or in combination, in participants…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 trial from AstraZeneca is evaluating novel drug combinations in participants with locally advanced unresectable or metastatic gast…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma [Phase 1]
First-in-human phase I/IIa trial evaluating DA 3501 in advanced gastric or gastroesophageal cancer and pancreatic ductal adenocarcinoma; cur…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer [Phase 1]
A Phase 1 trial is evaluating CA-4948 in combination with FOLFOX and a PD-1 inhibitor, with or without trastuzumab, for untreated unresectab…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Resilience and Equity in Aging, Cancer, and Health (REACH) [NA]
The REACH trial sponsored by Dana-Farber Cancer Institute is currently recruiting. It targets multiple gastrointestinal cancers including ga…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas [Phase 1]
Phase 1 trial evaluating different doses of BI 765049 in adults with advanced colorectal cancer, gastric cancer, or pancreatic ductal adenoc…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2 [Phase 2]
Phase 2 trial evaluating AZD0901 as monotherapy in adults with 2L+ advanced or metastatic gastric or GEJ adenocarcinoma expressing CLDN18.2.…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors [Phase 2]
A Phase 2 clinical trial of disitamab vedotin in combination with other anticancer drugs for solid tumors is currently recruiting, including…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 clinical trial is evaluating a first-line combination of trastuzumab deruxtecan (TDXd), chemotherapy, pembrolizumab, and trastuzum…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial [Phase 2]
A Phase II randomized trial is evaluating disitamab vedotin plus the SOX chemotherapy regimen versus SOX alone as adjuvant therapy in HER2-e…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis [Phase 2]
Phase 2 trial evaluating combined systemic and intraperitoneal chemotherapy for synchronous gastric and gastroesophageal peritoneal carcinom…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) [Phase 2]
A Phase 2 clinical trial evaluating ONO-4578 in combination with Nivolumab and chemotherapy in chemotherapy-naïve patients with HER2-negativ…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers [Phase 1]
This Phase 1 clinical trial update describes S095029 as monotherapy and in combination with Sym021 in patients with advanced solid tumors, f…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating Carilizumab with Albumin Paclitaxel as second-line therapy for advanced gastric cancer is currently recr…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer [NA]
A City of Hope Medical Center-sponsored clinical trial is evaluating risk assessment methods to identify individuals at high risk for stomac…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) [Phase 1]
Phase 1 clinical trial MK-7119-002 assesses safety and pharmacokinetics of tucatinib (MK-7119) in Chinese participants with cancer; the stud…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors [Phase 1, Phase 2]
A Mayo Clinic-sponsored phase 1/2 trial evaluating a personalized neoantigen peptide-based vaccine in combination with pembrolizumab for adv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy [Phase 4]
A Phase 4 randomized trial is evaluating reduced-port robotic subtotal gastrectomy versus conventional laparoscopic subtotal gastrectomy for…